1-20 of 38
John M. Venditti
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The importance of the pharmacology of luciferin and its effect on bioluminescent endpoints when conducting in vivo and in vitro experiments

Carrie A. Bonomi, Suzanne D. Borgel, John P. Carter, Jessica M. Zalek, John M. Venditti, Joseph G. Mayo, Sherman F. Stinson, Melinda G. Hollingshead
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 904.
Published: 01 May 2005
View article titled, The importance of the pharmacology of luciferin and its effect on bioluminescent endpoints when conducting in vivo and in vitro experiments
Journal Articles

In vitro and in vivo evaluations of leptomycin analogs which exhibit potent and differential anticancer activities

Michael C. Alley, Melinda G. Hollingshead, Christine M. Pacula-Cox, John M. Venditti, Thomas G. McCloud, Rhone K. Akee, David J. Newman
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 149.
Published: 01 May 2005
View article titled, <em>In vitro</em> and <em>in vivo</em> evaluations of leptomycin analogs which exhibit potent and differential anticancer activities
Journal Articles

Therapeutic and Pharmacological Studies of Tetrachloro(d,l-trans)1,2-diaminocyclohexane Platinum (IV) (Tetraplatin), a New Platinum Analogue

Aquilur Rahman, Jae Kyung Roh, Mary K. Wolpert-DeFilippes, Abraham Goldin, John M. Venditti, Paul V. Woolley
Journal: Cancer Research
Cancer Res (1988) 48 (7): 1745–1752.
Published: 01 April 1988
View article titled, Therapeutic and Pharmacological Studies of Tetrachloro(<em>d,l-trans</em>)1,2-diaminocyclohexane Platinum (IV) (Tetraplatin), a New Platinum Analogue
Open the PDF for Therapeutic and Pharmacological Studies of Tetrachloro(<em>d,l-trans</em>)1,2-diaminocyclohexane Platinum (IV) (Tetraplatin), a New Platinum Analogue in another window
Journal Articles

Application of a Human Tumor Colony-forming Assay to New Drug Screening

Robert H. Shoemaker, Mary K. Wolpert-DeFilippes, David H. Kern, Michael M. Lieber, Robert W. Makuch, Nannette R. Melnick, William T. Miller, Sydney E. Salmon, Richard M. Simon, John M. Venditti, Daniel D. Von Hoff
Journal: Cancer Research
Cancer Res (1985) 45 (5): 2145–2153.
Published: 01 May 1985
View article titled, Application of a Human Tumor Colony-forming Assay to New Drug Screening
Open the PDF for Application of a Human Tumor Colony-forming Assay to New Drug Screening in another window
Journal Articles

Adequacies and Inadequacies in Assessing Murine Toxicity Data with Antineoplastic Agents

Anthony M. Guarino, Marcel Rozencweig, Ira Kline, John S. Penta, John M. Venditti, Harris H. Lloyd, Donald A. Holzworth, Franco M. Muggia
Journal: Cancer Research
Cancer Res (1979) 39 (6_Part_1): 2204–2210.
Published: 01 June 1979
View article titled, Adequacies and Inadequacies in Assessing Murine Toxicity Data with Antineoplastic Agents
Open the PDF for Adequacies and Inadequacies in Assessing Murine Toxicity Data with Antineoplastic Agents in another window
Journal Articles

Potentiation of Actinomycin D or Adriamycin Antitumor Activity with DNA

Thomas A. Marks, John M. Venditti
Journal: Cancer Research
Cancer Res (1976) 36 (2_Part_1): 496–504.
Published: 01 February 1976
View article titled, Potentiation of Actinomycin D or Adriamycin Antitumor Activity with DNA
Open the PDF for Potentiation of Actinomycin D or Adriamycin Antitumor Activity with DNA in another window
Journal Articles

Immunity to a TA3 Tumor Subline That Grows in Allogeneic Hosts Elicited by Strain-specific TA3 Tumor Cells

Muriel M. Lippman, John M. Venditti, Ira Kline, David L. Elam
Journal: Cancer Research
Cancer Res (1973) 33 (4): 679–684.
Published: 01 April 1973
View article titled, Immunity to a TA3 Tumor Subline That Grows in Allogeneic Hosts Elicited by Strain-specific TA3 Tumor Cells
Open the PDF for Immunity to a TA3 Tumor Subline That Grows in Allogeneic Hosts Elicited by Strain-specific TA3 Tumor Cells in another window
Journal Articles

Evaluation of Combination Chemotherapy with Three Drugs

Abraham Goldin, John M. Venditti, Nathan Mantel, Ira Kline, Miriam Gang
Journal: Cancer Research
Cancer Res (1968) 28 (5): 950–960.
Published: 01 May 1968
View article titled, Evaluation of Combination Chemotherapy with Three Drugs
Open the PDF for Evaluation of Combination Chemotherapy with Three Drugs in another window
Journal Articles

Separate and Sequential Chemotherapy of Mouse Leukemia L1210 with 1-β-d-Arabinofuranosylcytosine Hydrochloride and 1,3-Bis(2-chloroethyl)-1-nitrosourea1

Denis D. Tyrer, Ira Kline, John M. Venditti, Abraham Goldin
Journal: Cancer Research
Cancer Res (1967) 27 (5_Part_1): 873–879.
Published: 01 May 1967
View article titled, Separate and Sequential Chemotherapy of Mouse Leukemia L1210 with 1-β-<sc>d</sc>-Arabinofuranosylcytosine Hydrochloride and 1,3-Bis(2-chloroethyl)-1-nitrosourea<sup>1</sup>
Open the PDF for Separate and Sequential Chemotherapy of Mouse Leukemia L1210 with 1-β-<sc>d</sc>-Arabinofuranosylcytosine Hydrochloride and 1,3-Bis(2-chloroethyl)-1-nitrosourea<sup>1</sup> in another window
Journal Articles

Chemotherapy of Leukemia L1210 in Mice with 1-β-d-Arabinofuranosylcytosine Hydrochloride: II. Effectiveness against Intracerebrally and Subcutaneously Inoculated Leukemic Cells1

Ira Kline, John M. Venditti, Denis D. Tyrer, Nathan Mantel, Abraham Goldin
Journal: Cancer Research
Cancer Res (1966) 26 (9_Part_1): 1930–1937.
Published: 01 September 1966
View article titled, Chemotherapy of Leukemia L1210 in Mice with 1-β-<sc>d</sc>-Arabinofuranosylcytosine Hydrochloride: <subtitle>II. Effectiveness against Intracerebrally and Subcutaneously Inoculated Leukemic Cells<sup>1</sup></subtitle>
Open the PDF for Chemotherapy of Leukemia L1210 in Mice with 1-β-<sc>d</sc>-Arabinofuranosylcytosine Hydrochloride: <subtitle>II. Effectiveness against Intracerebrally and Subcutaneously Inoculated Leukemic Cells<sup>1</sup></subtitle> in another window
Journal Articles

The Antileukemic Effectiveness of 5-Fluorouracil and Methotrexate in the Combination Chemotherapy of Advanced Leukemia L1210 in Mice

Ira Kline, John M. Venditti, J. A. R. Mead, Denis D. Tyrer, Abraham Goldin
Journal: Cancer Research
Cancer Res (1966) 26 (5): 848–852.
Published: 01 May 1966
View article titled, The Antileukemic Effectiveness of 5-Fluorouracil and Methotrexate in the Combination Chemotherapy of Advanced Leukemia L1210 in Mice
Open the PDF for The Antileukemic Effectiveness of 5-Fluorouracil and Methotrexate in the Combination Chemotherapy of Advanced Leukemia L1210 in Mice in another window
Journal Articles

Chemotherapy of Leukemia L1210 in Mice with 1-β-d-Arabinofuranosylcytosine Hydrochloride: I. Influence of Treatment Schedules1

Ira Kline, John M. Venditti, Denis D. Tyrer, Abraham Goldin
Journal: Cancer Research
Cancer Res (1966) 26 (5): 853–859.
Published: 01 May 1966
View article titled, Chemotherapy of Leukemia L1210 in Mice with 1-β-<sc>d</sc>-Arabinofuranosylcytosine Hydrochloride: <subtitle>I. Influence of Treatment Schedules<sup>1</sup></subtitle>
Open the PDF for Chemotherapy of Leukemia L1210 in Mice with 1-β-<sc>d</sc>-Arabinofuranosylcytosine Hydrochloride: <subtitle>I. Influence of Treatment Schedules<sup>1</sup></subtitle> in another window
Journal Articles

Chemotherapy of Advanced Mouse Leukemia L1210: Comparison of Methotrexate Alone and in Sequential Therapy*

John M. Venditti, Abraham Goldin
Journal: Cancer Research
Cancer Res (1964) 24 (8): 1457–1460.
Published: 01 September 1964
View article titled, Chemotherapy of Advanced Mouse Leukemia L<sc>1210</sc>: Comparison of Methotrexate Alone and in Sequential Therapy*
Open the PDF for Chemotherapy of Advanced Mouse Leukemia L<sc>1210</sc>: Comparison of Methotrexate Alone and in Sequential Therapy* in another window
Journal Articles

Evaluation of Antileukemic Agents Employing Advanced Leukemia L1210 in Mice. VIII

John M. Venditti, Ira Kline, Abraham Goldin
Journal: Cancer Research
Cancer Res (1964) 24 (6_Part_2): 827–879.
Published: 01 July 1964
View article titled, Evaluation of Antileukemic Agents Employing Advanced Leukemia L1210 in Mice. VIII
Open the PDF for Evaluation of Antileukemic Agents Employing Advanced Leukemia L1210 in Mice. VIII in another window
Journal Articles

Evaluation of Antileukemic Agents Against Mouse Leukemia P1534

Czeslaw Radzikowski, Nathaniel H. Greenberg, June L. Biedler, John M. Venditti
Journal: Cancer Research
Cancer Res (1964) 24 (3_Part_2): 461–472.
Published: 01 April 1964
View article titled, Evaluation of Antileukemic Agents Against Mouse Leukemia P1534
Open the PDF for Evaluation of Antileukemic Agents Against Mouse Leukemia P1534 in another window
Journal Articles

Evaluation of Antileukemic Agents in the Treatment of Drug Resistant Variants of Leukemia L1210

John M. Venditti, Abraham Goldin, Ira Kline, Donald R. Sheldon
Journal: Cancer Research
Cancer Res (1963) 23 (6_Part_2): 1011–1084.
Published: 01 July 1963
View article titled, Evaluation of Antileukemic Agents in the Treatment of Drug Resistant Variants of Leukemia L1210
Open the PDF for Evaluation of Antileukemic Agents in the Treatment of Drug Resistant Variants of Leukemia L1210 in another window
Journal Articles

Effectiveness of 2-Chloro-4′, 4″-di-2-imidazolin-2-ylterephthalanilide and Methotrexate, in Combination, against Advanced Leukemia L1210

John M. Venditti, Abraham Goldin, Ira Kline
Journal: Cancer Research
Cancer Res (1963) 23 (4_Part_1): 593–599.
Published: 01 May 1963
View article titled, Effectiveness of 2-Chloro-4′, 4″-di-2-imidazolin-2-ylterephthalanilide and Methotrexate, in Combination, against Advanced Leukemia L1210
Open the PDF for Effectiveness of 2-Chloro-4′, 4″-di-2-imidazolin-2-ylterephthalanilide and Methotrexate, in Combination, against Advanced Leukemia L1210 in another window
Journal Articles

Evaluation of Antileukemic Agents Employing Advanced Leukemia L-1210 in Mice. VI.

Abraham Goldin, John M. Venditti, Ira Kline
Journal: Cancer Research
Cancer Res (1962) 22 (8_Part_2): 749–835.
Published: 01 September 1962
View article titled, Evaluation of Antileukemic Agents Employing Advanced Leukemia L-1210 in Mice. VI.
Open the PDF for Evaluation of Antileukemic Agents Employing Advanced Leukemia L-1210 in Mice. VI. in another window
Journal Articles

Toxicity and Antileukemic Effectiveness of Pyridine Derivatives and 1,3,4-Thiadiazole Derivatives in Mice. Relationship to Nicotinamide Antagonism

Stewart R. Humphreys, John M. Venditti, Charles J. Ciotti, Ira Kline, Abraham Goldin, Nathan O. Kaplan
Journal: Cancer Research
Cancer Res (1962) 22 (5_Part_2): 483–550.
Published: 01 June 1962
View article titled, Toxicity and Antileukemic Effectiveness of Pyridine Derivatives and 1,3,4-Thiadiazole Derivatives in Mice. Relationship to Nicotinamide Antagonism
Open the PDF for Toxicity and Antileukemic Effectiveness of Pyridine Derivatives and 1,3,4-Thiadiazole Derivatives in Mice. Relationship to Nicotinamide Antagonism in another window
Journal Articles

Evaluation of Antileukemic Agents Employing Advanced Leukemia L-1210 in Mice. V.

Abraham Goldin, John M. Venditti, Ira Kline
Journal: Cancer Research
Cancer Res (1962) 22 (4_Part_2): 157–220.
Published: 01 May 1962
View article titled, Evaluation of Antileukemic Agents Employing Advanced Leukemia L-1210 in Mice. V.
Open the PDF for Evaluation of Antileukemic Agents Employing Advanced Leukemia L-1210 in Mice. V. in another window